Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gaps: practical implications]

H Poty1, N Saoudi, F Anselme

  • 1Service de cardiologie, hôpital Charles-Nicolle, Rouen.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New prognostic and predictive scoring systems for colorectal cancer liver metastases.

ESMO open·2026
Same author

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

ESMO gastrointestinal oncology·2026
Same author

[Accessibility to TAVI in a center without cardiac surgery : a Corsican example].

Annales de cardiologie et d'angeiologie·2025
Same author

Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Sex and gender perspectives in colorectal cancer.

ESMO open·2023
Same author

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

The conduction gap is a cardiac cycle period where premature beats are blocked, crucial for understanding reentrant arrhythmias and guiding ablation therapy.

Area of Science:

  • Electrophysiology
  • Cardiac Arrhythmia Mechanisms

Context:

  • The conduction gap, also known as the gap phenomenon, describes a specific period in the cardiac cycle.
  • This phenomenon involves the blocking of premature cardiac beats while others are conducted.

Purpose:

  • To define the conduction gap and its underlying electrophysiological mechanisms.
  • To elucidate the role of the excitability gap in reentrant arrhythmias.
  • To explore diagnostic and therapeutic applications of understanding the excitability gap.

Summary:

  • The conduction gap occurs when premature beats are blocked due to delayed proximal conduction, allowing distal sites to regain excitability.
  • The excitability gap is fundamental to reentrant arrhythmias, ensuring their stability and allowing external stimuli to interact with the circuit.

Related Experiment Videos

  • Techniques like resetting and entrainment pacing leverage the excitability gap for diagnosis and therapy, including identifying critical zones for ablation and terminating arrhythmias.

    • Impact:

    • Enables precise identification of arrhythmia circuits and critical zones for targeted ablation.
    • Provides a basis for terminating arrhythmias through external stimulation techniques.
    • Guides the selection of antiarrhythmic agents for pharmacological cardioversion of reentrant tachycardias.